Skip to main content
OpenTrials
Completed

NCT Number: NCT02156154

Effect of Intravenous Acetaminophen on Postoperative Opioid-related Complications

Some patients have respiratory depression (decreased breaths per minute) after surgery. Acetaminophen, an FDA approved pain medication, may prevent this problem. The purpose of this study is to determine if acetaminophen decreases respiratory depression after surgery. The investigators will also evaluate the cost effectiveness of acetaminophen.

Patients having elective major abdominal surgery are being asked to participate in this research study. If eligible, a patient will have their baseline tidal volume (amount of air moved into or out of the lungs) and vital capacity (how much air the lungs are capable of holding) measured using a spirometer (apparatus for measuring the volume of air inspired and expired by the lungs) measured before surgery. Three questionnaires will also need to be completed before surgery.

The patient will then be randomized, like flipping a coin, to receive either Acetaminophen or placebo (inactive substance) as an infusion throughout surgery and for the first two days thereafter. Neither the patient nor his or her physician will know if the patient is assigned to study drug or placebo. Regardless of study assignment, both groups will receive standard pain management medications and sedation.

After surgery, the patient's blood pressure, activity, posture, respiratory rate, the electrical activity of the heart, oxygen saturation, tidal volume, minute ventilation and respiratory rate will be continuously monitored and recorded for 48 hours using a wireless pulse-oximeter and a respiratory volume monitor.

48 hours after surgery the patient will be asked to complete a patient satisfaction questionnaire, which will allow the patient to rate the satisfaction with the treatment received for pain. The patient will also be asked to complete a questionnaire about recovery.

At discharge, the patient will be given two questionnaires about pain and quality of life.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–85 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

Cleveland Clinic Foundation

Cleveland, Ohio, 44195, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Written informed consent
  • 18-85 years old
  • above 50 kg
  • American Society of Anaesthesiologists Physical Status 1-3
  • Scheduled for elective open or laparoscopic abdominal surgery, including colorectal, prostate, and hysterectomy surgeries
  • Patients with anticipated hospitalization of two nights
  • Expected to require parenteral opioids for at least 48 hours for postoperative pain
  • Able to use IV Patient-Controlled Analgesia systems

Exclusion criteria

  • Hepatic disease, e.g. twice the normal levels of liver enzymes
  • Kidney disease, e.g. twice the normal level of serum creatinine
  • Epidural analgesia or regional blocks (including Transverse abdominis plane block)
  • Acetaminophen sensitivity or known allergy
  • Female patients who are pregnant or breastfeeding
  • Patients taking warfarin

Treatment and study plan

Intravenous acetaminophen

Drug

Primary outcomes

  1. Duration of Hypoxemia

    Time frame: the initial 48 hours of postoperative monitoring or for the duration of hospitalization, if shorter.

    Hypoxemia is measured as minutes with hypoxemia (Spo2 <90%) per hour of successful Spo2 monitoring. Patients will have nearly continuous pulseoximeter monitoring and recording. Data from the monitor will be downloaded daily for 48 hours postoperatively.

Secondary outcomes

  1. Time-weighted Pain Score During Initial 48 Postoperative Hours

    Time frame: Initial 48 postoperative hours or duration of hospitalization (whichever comes first)

    Pain scores were calculated on a visual analog scale of 0 to 10, with 0 being no pain and 10 being the most pain imaginable; time weighted mean was calculated as the area under the curve of the pain score measurements divided by total measurement time. Pain was recorded at roughly 15-minute intervals in the postanesthesia care unit and at 4-hour intervals on surgical wards

  2. Time Weighted Pain Score in Post Anesthesia Care Unit

    Time frame: Initial 48 postoperative hours or duration of hospitalization (whichever comes first)

    Pain scores were calculated on a visual analog scale of 0 to 10, with 0 being no pain and 10 being the most pain imaginable; time-weighted mean was calculated as the area under the curve of the pain score measurements divided by total measurement time.

  3. Fatigue Score on Morning of Postoperative Day 1

    Time frame: Postoperative day 1

    Fatigue scores were calculated on a scale of 1 to 10, with 1 being no fatigue and 10 being the worst fatigue imaginable.

  4. Lowest RASS Score During Initial 48 Postoperative Hours

    Time frame: Initial 48 postoperative hours or duration of hospitalization (whichever comes first)

    Sedation was estimated by the RASS score and recorded at 2-hour intervals by ward nurses per clinical routine during the initial 48 postoperative hours. The Richmond Agitation-Sedation Scale (RASS) is scored from -5 to +4, with -5 being unarousable, 0 being alert and calm, and +4 being combative.

  5. Time Spent in Sitting or Upright Position

    Time frame: Initial 48 postoperative hours or duration of hospitalization (whichever comes first)

    Treatment effect data are reported as ratios of geometric means

  6. Opioid Consumption - Intravenous Morphine Equivalents

    Time frame: Initial 48 postoperative hours

    Total opioid consumption over the initial 48 postoperative hours was extracted from patients' medical records and converted to intravenous morphine equivalents

  7. Incidence of Postoperative Nausea and Vomiting

    Time frame: Initial 48 postoperative hours or duration of hospitalization (whichever comes first)

    Patients were asked about postoperative nausea and vomiting in the postanesthesia care unit, at 4-hour intervals while awake through the remaining initial day of surgery, and on the first and second postoperative mornings.

  8. Incidence of Low Respiratory Function Event

    Time frame: Initial 48 postoperative hours or duration of hospitalization (whichever comes first)

    A low respiratory function event was defined as an episode of less than 40% of predicted minute ventilation for 2 minutes.

  9. Total Anesthetic Dose From Induction to Extubation

    Time frame: Induction to extubation (3 hours on average)

    Total anesthetic dose is measured in minimal alveolar concentration hours.

Sponsors and collaborators

Lead sponsor

The Cleveland Clinic

Other

Registry information

Important dates

Study start
2014
Primary completion
2019
Study completion
2020
First posted
Jun 5, 2014
Registry last updated
Apr 20, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.